Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Excision Biotherapeutics Inc.
Headquarters: Philadelphia, PA, United States of America
Website: https://www.excision.bio/
Year Founded: 2015
Status: Private
BioCentury | Apr 26, 2024
Finance
Venture report: Arch, Foresite $1B AI play Xaira starting with Baker lab’s de novo biologics
Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
BioCentury | Feb 8, 2024
Management Tracks
New chair, CFO for I-Mab as part of U.S. push
Plus: Artios hires Silverstein as CFO and updates from Astellas, atai, Cartography, Corvus and Helio
BioCentury | Sep 16, 2022
Finance
Sept. 15 Quick Takes: Khosla seeds Cas13 company Carver
Plus RGImmune launches with F-Prime’s backing and updates from Pfizer, Tridek-One
BioCentury | Jan 26, 2022
Data Byte
Herpes simplex virus pipeline
Small molecules lead, with antibodies, gene therapies, vaccines and nanoparticles also in the lineup
BioCentury | Jan 20, 2022
Product Development
Moving beyond a 45-year-old antiviral for herpes
Improved antivirals, antibodies, vaccines and possible cures enter the horizon
BioCentury | Oct 13, 2021
Management Tracks
Harler joins IGM as president of autoimmunity and inflammation business
Plus: Precigen, Transition Bio, Shoreline, Syros, Twist, Vor and more
BioCentury | Aug 4, 2021
Management Tracks
Arbuckle becomes COO at Vertex
Plus: GlycoMimetics names Semerjian as King’s successor, plus updates from Pieris, Assembly and more
BioCentury | May 27, 2021
Management Tracks
Kelly named CFO at Precision; plus EpimAb, TScan, Magenta, Tectonic and more
Precision BioSciences Inc. (NASDAQ:DTIL) named Alex Kelly CFO. Kelly joined the gene editing company as chief corporate affairs officer in October 2020 and has served as interim CFO since
BioCentury | May 26, 2021
Management Tracks
Kim joins Orum as CFO; plus Neogene, Praxis, Sangamo, C4 and more
South Korea-based protein degradation play Orum Therapeutics Inc. hired Jae Won Kim as CFO. Kim was director of the healthcare investment banking team at Citi. T cell therapy company
BioCentury | May 5, 2021
Management Tracks
Shearman named Editas CSO; plus Kyowa Kirin, Excision, IDbyDNA, and more
Mark Shearman will join Editas Medicine Inc. (NASDAQ:EDIT) in June as EVP and CSO. Shearman currently serves as CSO of Applied Genetic Technologies Corp. (NASDAQ:AGTC). Kyowa Kirin Co. Ltd.
Items per page:
1 - 10 of 30